Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

FDA Approves Amturnide

December 23, 2010 5:30 am | News | Comments

Novartis AG said the Food and Drug Administration approved Amturnide, a high blood pressure combination pill that includes Novartis' drug Tekturna.


Abbott Recalling Millions of Testing Strips

December 23, 2010 5:27 am | News | Comments

The Food and Drug Administration said that Abbott Laboratories is recalling up to 359 million testing strips used by diabetics because they can give falsely low blood sugar readings.


Eli And Amylin Ask for Expanded Byetta Approval

December 23, 2010 4:56 am | News | Comments

Eli Lilly and Co. and Amylin Pharmaceuticals Inc. said they are asking the Food and Drug Administration to expand approval for their type 2 diabetes drug Byetta.


Web-Reporting Service

December 22, 2010 7:38 am | Product Releases | Comments

Two Fold Software Limited has created a web reporting module for its Qualoupe LIMS solution that allows organisations such as contract laboratories or manufacturing companies to access and run LIMS reports on demand in a more cost-efficient way.


Diamond-Like Coating

December 22, 2010 7:27 am | Product Releases | Comments

SGE Analytical Science has been awarded a grant to help develop a new diamond-like coating technology. Diamond-like coating technology, or plasma-activated high-frequency vacuum deposition, has low friction and is extremely durable.


Merrion Collaborating With Novo Nordisk

December 22, 2010 7:19 am | News | Comments

Merrion Pharmaceuticals Plc announced the signing of a Collaboration and Option agreement with Novo Nordisk. The agreement will evaluate the ability of Merrion's patented GIPET technology to boost the oral bioavailability of an undisclosed compound.


MorphoSys Receives Centocor Milestone Payment

December 22, 2010 7:14 am | News | Comments

MorphoSys AG has received a clinical milestone payment from Centocor Ortho Biotech Inc. for a clinical trial application for a phase 1 clinical trial of a HuCAL-derived antibody in the therapeutic area of inflammatory and autoimmune diseases.


Cancer Stem Cells Bode Poor Prognosis

December 22, 2010 6:53 am | News | Comments

Researchers have found that leukemia patients whose cancers express higher levels of genes associated with cancer stem cells have a significantly poorer prognosis than patients with lower levels of the genes.


CTCs Related to Worse Outcomes in Head/Neck Cancer

December 22, 2010 6:49 am | News | Comments

A study suggests that the presence of tumor cells in the circulating blood of patients with squamous cell cancer of the head and neck may predict disease recurrence and reduced survival; it also correlates with a worse outcome.


AMR-001 Demonstrates Effectiveness in AMI

December 22, 2010 6:43 am | News | Comments

The American Heart Journal reported results of a clinical trial evaluating Amorcyte, Inc.’s lead product candidate, AMR-001 for the treatment of damaged heart muscle following acute myocardial infarction.


Tekmira Begins Phase 1 Cancer Trial

December 22, 2010 6:38 am | News | Comments

Tekmira Pharmaceuticals Corporation, a developer of RNA interference therapeutics, announced it has initiated patient dosing in a Phase 1 human clinical trial for its lead oncology product, TKM-PLK1.


Biogen And Elan to Update Tysabri Info

December 22, 2010 6:36 am | News | Comments

Biogen Idec and Elan Corp. said they have applied to U.S. and European regulators to update prescribing information for the multiple sclerosis drug Tysabri to help classify the risk of a rare but serious brain infection.


Ligand to Receive $1M from Pfizer

December 22, 2010 6:34 am | News | Comments

Ligand Pharmaceuticals Inc. said it will receive a $1 million payment from Pfizer Inc. as part of a partnership for the potential contraceptive Tanaproget.


Pfizer Settles Breast Cancer Lawsuits

December 22, 2010 6:33 am | News | Comments

Two pharmaceutical companies have agreed to a settlement with two Nevada women who claimed hormone replacement drugs caused their breast cancer.


Teva to Sell Generic Actos

December 22, 2010 6:31 am | News | Comments

Teva Pharmaceutical Industries Ltd. said it will start selling a generic version of the diabetes drug Actos after settling a patent infringement lawsuit brought by the company that makes Actos, Takeda Pharmaceutical Co.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.